CytomX Therapeutics, Inc

VistaGen Therapeutics, Inc is a biopharmaceutical company based in South San Francisco, CA, specializing in the development of innovative therapies for mental health disorders. With a focus on utilizing cutting-edge technology and research, VistaGen Therapeutics, Inc aims to address unmet medical needs and improve the lives of patients through its novel drug candidates. Generated from their business information

Cairn Biosciences is a San Francisco-based biotech company that specializes in discovering new medicines by mapping multiscale cell dynamics. Their proprietary COMPASS discovery platform utilizes innovative simulations of living biology to navigate complex disease biology and unlock exclusive routes to novel targets and drugs, with a focus on overcoming acquired resistance to targeted cancer therapies. With a diverse and multidisciplinary team of experts in drug discovery, disease biology, engineering, and computation, Cairn Biosciences is pioneering a new drug discovery paradigm. Their team, led by established biopharma leader and serial drug discovery innovator Mary Ludlam, is dedicated to delivering better therapeutics through their expertise in synthetic cell biology, high-throughput microscopy, computational analysis, and more.Generated from the website

Abbott Diabetes Care, located in Alameda, Calif., designs, develops and manufactures several glucose monitoring systems and test strips for use in both home and hospital settings. Among its brands are FreeStyle, FreeStyle Flash, Precision Xtra and Precision PCx. Abbott entered the blood glucose monitoring marketplace with the acquisition of MediSense in 1996. In 2004, the company acquired TheraSense, a leader in developing blood glucose self-monitoring devices that require very small blood samples to deliver rapid test results. ADC is a subsidiary of Abbott Laboratories, a global health care company devoted to the discovery of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.